We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.12B
AUM Growth
+$54.5M
Cap. Flow
+$26.3M
Cap. Flow %
2.35%
Top 10 Hldgs %
29.48%
Holding
398
New
28
Increased
109
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.6M
2
PYPL icon
PayPal
PYPL
+$8.22M
3
GILD icon
Gilead Sciences
GILD
+$7.14M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.62M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$2.36M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
URI icon
United Rentals
URI
+$6.93M
3
LMT icon
Lockheed Martin
LMT
+$2.69M
4
AAPL icon
Apple
AAPL
+$2.39M
5
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 18.15%
2 Technology 17.83%
3 Financials 12.37%
4 Industrials 9.95%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
URI icon
1
United Rentals
URI
$71.1B
$39.5M 3.54%
88,802
-18,702
-17% -$6.93M
DHI icon
2
D.R. Horton
DHI
$41B
$36M 3.22%
295,522
+2,165
+0.7% +$237K
ON icon
3
ON Semiconductor
ON
$33.8B
$35.8M 3.2%
378,752
+3,283
+0.9% +$272K
AMP icon
4
Ameriprise Financial
AMP
$46.8B
$35.2M 3.15%
105,985
+1,362
+1% +$419K
REGN icon
5
Regeneron Pharmaceuticals
REGN
$68.8B
$32.7M 2.92%
45,475
+3,393
+8% +$2.62M
LMT icon
6
Lockheed Martin
LMT
$134B
$32.1M 2.88%
69,827
-5,800
-8% -$2.69M
CDW icon
7
CDW
CDW
$17.1B
$31.1M 2.79%
169,724
+1,635
+1% +$286K
TMO icon
8
Thermo Fisher Scientific
TMO
$211B
$29.6M 2.64%
56,638
+440
+0.8% +$237K
GOOG icon
9
Alphabet (Google) Class C
GOOG
$3.9T
$29.1M 2.6%
240,480
+6,600
+3% +$764K
AVDE icon
10
Avantis International Equity ETF
AVDE
$17.7B
$28.5M 2.55%
496,070
+29,380
+6% +$1.7M
HOLX
11
DELISTED
Hologic
HOLX
$27.7M 2.48%
342,633
+4,901
+1% +$401K
CSCO icon
12
Cisco
CSCO
$450B
$27M 2.41%
521,850
+4,393
+0.8% +$216K
MA icon
13
Mastercard
MA
$477B
$26.2M 2.34%
66,661
+267
+0.4% +$100K
FITB
14
Fifth Third Bancorp
FITB
$52B
$26.1M 2.34%
996,255
+3,867
+0.4% +$99.7K
GILD icon
15
Gilead Sciences
GILD
$161B
$26M 2.32%
336,749
+89,479
+36% +$7.14M
ABBV icon
16
AbbVie
ABBV
$458B
$25.5M 2.28%
189,226
+3,145
+2% +$461K
AAPL icon
17
Apple
AAPL
$4.89T
$24.6M 2.2%
126,972
-13,691
-10% -$2.39M
PYPL icon
18
PayPal
PYPL
$49.5B
$24M 2.15%
359,884
+120,622
+50% +$8.22M
JAAA icon
19
Janus Henderson AAA CLO ETF
JAAA
$29.1B
$24M 2.14%
481,002
+11,351
+2% +$563K
SONY icon
20
Sony
SONY
$123B
$23.1M 2.07%
1,282,285
+25,700
+2% +$482K
GNRC icon
21
Generac Holdings
GNRC
$11.9B
$21.1M 1.89%
141,432
+7,173
+5% +$818K
PLTR icon
22
Palantir
PLTR
$295B
$18.6M 1.66%
1,212,941
+25,293
+2% +$287K
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$121B
$18.4M 1.64%
+52,175
New +$17.6M
JBBB icon
24
Janus Henderson B-BBB CLO ETF
JBBB
$1.4B
$17.5M 1.56%
380,914
+7,220
+2% +$328K
SHY icon
25
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$17M 1.52%
209,365
+7,710
+4% +$630K
1
2 3 4 5

Similar funds

KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return
PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return

Atwood & Palmer's Q2 2023 Portfolio in Review

As of Q2 2023, Atwood & Palmer held 398 positions worth $1.12B, up 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Atwood & Palmer's Q2 2023 filing shows 28 new, 109 increased, 39 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 52,175 shares worth $18.4M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q2 2023 buy was Vertex Pharmaceuticals: 52,175 shares worth $18.4M.
  • Atwood & Palmer added most to PayPal in Q2 2023, an estimated $8.22M increase.
  • Atwood & Palmer's biggest Q2 2023 reduction was Amgen, cutting an estimated $19.6M.
  • Atwood & Palmer fully exited First Trust Materials AlphaDEX Fund in Q2 2023, selling an estimated $217K.
  • Atwood & Palmer's ten largest holdings make up 29% of its $1.12B portfolio in Q2 2023.
  • Atwood & Palmer opened 28 new positions and closed 2 in Q2 2023.
  • Atwood & Palmer's portfolio value rose 5.1% quarter-over-quarter to $1.12B.

Based on Atwood & Palmer's 13F filing for Q2 2023, filed 18 Jul 2023.